Method of treating or ameliorating metabolic disorders using growth differentiation factor 15 (GDF-15)
US10752664B2 · kind B2 · utility
3Cited by
12References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 2012 |
| Grant date | Aug 25, 2020 |
| Priority date | — |
| Expiry date | Jun 3, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating metabolic diseases and disorders using a GDF15 polypeptide are provided. In various embodiments the metabolic disease or disorder is type 2 diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels and diabetic nephropathy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.